Pharmacological targeting of myoferlin sensitizes pancreatic cancer cells to ferroptosis
The Metastasis Research Laboratory (O. Peulen and A. Bellahcène) provides new insight into the importance of myoferlin in pancreatic cancer. Its pharmacological targeting sensitizes PDAC cells to ferroptosis.